# Trump admin moves to allow peptide drugs for wellness products

> Trump administration advances plan to let pharmacies make unapproved peptide drugs popular with health advocates.
- Title: Trump admin moves to allow peptide drugs for wellness products
- Summary: Trump administration advances plan to let pharmacies make unapproved peptide drugs popular with health advocates. Trump administration submits policy to…
- Keywords: peptide drugs, robert f kennedy jr, health secretary, specialty pharmacies, fda, wellness influencers, make america healthy again, news, local, Trump, admin, moves
- Source: Seattletimes — https://seattletimes.com/business/trump-administration-advances-plan-for-peptide-drugs-favored-by-rfk-jr
- Read time: 1 min
- Topics: peptide drugs, robert f kennedy jr, health secretary, specialty pharmacies, fda, wellness influencers, make america healthy again, news, local
## Trump admin submits peptide policy
U.S. health officials move ahead with plan to let specialty pharmacies produce certain peptides popular among Health Secretary Robert F. Kennedy Jr. and wellness influencers.
## Peptides are unregulated injections
Peptides are building blocks of proteins that trigger hormones for growth, metabolism and healing but lack FDA approval for most uses.
## Kennedy pushes for peptide access
Kennedy previously declared FDA’s war on peptides would end and urged compounding pharmacies to sell gray market peptides from China.
## Policy allows temporary peptide production
The White House filing lets pharmacies temporarily compound popular peptides like BPC-157 for muscle building and injury healing.
## FDA previously restricted peptides
FDA listed BPC-157 and over a dozen peptides as too risky for pharmacy compounding due to contamination and allergic reactions.
## Kennedy directs FDA to reconsider
Kennedy ordered FDA to review chemicals promoted by wellness influencers after a panel recommended dropping restrictions on six peptides.
## Peptide market could reach $2 billion
Telehealth providers and Wall Street analysts estimate the unregulated peptide market could be worth $2 billion to $3 billion.
## Key takeaway

Trump administration submits policy to allow specialty pharmacies to produce unregulated peptide injections favored by Health Secretary Robert F. Kennedy Jr. and wellness influencers.